Ethanol and hydrazine sulfate induced chronic hepatic injury in rats: the curative effect of administration of glucogenic amino acids. 1993

H Suzuki, and T Tominaga, and H Mizuno, and M Kouno, and M Suzuki, and Y Kato, and A Sato, and K Okabe, and T Uchikoshi, and K Maezono
Department of Internal Medicine, St. Marianna University School of Medicine, Yokohama, Japan.

There is a widespread belief that when ethanol is fed to rats for a long time, it produces only fatty degeneration without necrosis or fibrosis. In this study, hydrazine sulfate, an inhibitor of low Km ALDH and gluconeogenetic enzymes, was fed with ethanol to rats, and produced more serious pathological changes compared with those found in Lieber's model. Male Sprague-Dawley rats were fed with a low fat liquid diet as a basal diet with ethanol (4%, w/v) and hydrazine sulfate for 4 weeks. At the end of the experiment, plasma aminotransferase levels were found to be elevated. Histological examination showed not only fatty degeneration but also pericellular fibrosis. Therefore, we have evaluated the curative effect of glucogenic amino acids, alanine and glutamine, on this hepatic injury model and found them to be partially protective.

UI MeSH Term Description Entries
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D008297 Male Males
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002149 Energy Intake Total number of calories taken in daily whether ingested or by parenteral routes. Caloric Intake,Calorie Intake,Intake, Calorie,Intake, Energy
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D005235 Fatty Liver, Alcoholic Lipid infiltration of the hepatic parenchymal cells that is due to ALCOHOL ABUSE. The fatty changes in the alcoholic fatty liver may be reversible, depending on the amounts of TRIGLYCERIDES accumulated. Alcoholic Fatty Liver,Alcoholic Steatohepatitis
D005723 gamma-Glutamyltransferase An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; (GSH, a tripeptide that protects cells from many toxins). It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid. GGTP,Glutamyl Transpeptidase,gammaglutamyltransferase,gamma-Glutamyl Transpeptidase,Transpeptidase, Glutamyl,Transpeptidase, gamma-Glutamyl,gamma Glutamyl Transpeptidase,gamma Glutamyltransferase
D005943 Gluconeogenesis Biosynthesis of GLUCOSE from nonhexose or non-carbohydrate precursors, such as LACTATE; PYRUVATE; ALANINE; and GLYCEROL.

Related Publications

H Suzuki, and T Tominaga, and H Mizuno, and M Kouno, and M Suzuki, and Y Kato, and A Sato, and K Okabe, and T Uchikoshi, and K Maezono
March 2020, Biological & pharmaceutical bulletin,
H Suzuki, and T Tominaga, and H Mizuno, and M Kouno, and M Suzuki, and Y Kato, and A Sato, and K Okabe, and T Uchikoshi, and K Maezono
January 1992, Biochimica et biophysica acta,
H Suzuki, and T Tominaga, and H Mizuno, and M Kouno, and M Suzuki, and Y Kato, and A Sato, and K Okabe, and T Uchikoshi, and K Maezono
January 2003, Amino acids,
H Suzuki, and T Tominaga, and H Mizuno, and M Kouno, and M Suzuki, and Y Kato, and A Sato, and K Okabe, and T Uchikoshi, and K Maezono
October 2009, Indian journal of clinical biochemistry : IJCB,
H Suzuki, and T Tominaga, and H Mizuno, and M Kouno, and M Suzuki, and Y Kato, and A Sato, and K Okabe, and T Uchikoshi, and K Maezono
September 2014, Chemico-biological interactions,
H Suzuki, and T Tominaga, and H Mizuno, and M Kouno, and M Suzuki, and Y Kato, and A Sato, and K Okabe, and T Uchikoshi, and K Maezono
January 1973, Journal of pharmaceutical sciences,
H Suzuki, and T Tominaga, and H Mizuno, and M Kouno, and M Suzuki, and Y Kato, and A Sato, and K Okabe, and T Uchikoshi, and K Maezono
October 1986, Biochemical medicine and metabolic biology,
H Suzuki, and T Tominaga, and H Mizuno, and M Kouno, and M Suzuki, and Y Kato, and A Sato, and K Okabe, and T Uchikoshi, and K Maezono
May 2003, Biochemical pharmacology,
H Suzuki, and T Tominaga, and H Mizuno, and M Kouno, and M Suzuki, and Y Kato, and A Sato, and K Okabe, and T Uchikoshi, and K Maezono
July 2009, Amino acids,
H Suzuki, and T Tominaga, and H Mizuno, and M Kouno, and M Suzuki, and Y Kato, and A Sato, and K Okabe, and T Uchikoshi, and K Maezono
May 1997, British journal of pharmacology,
Copied contents to your clipboard!